The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients

This publication has 25 references indexed in Scilit:

• SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
  Transplantation, 1999
• IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1
  Transplantation, 1998
• Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
  Clinical Biochemistry, 1998
• HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN)
  Transplantation, 1998
• Pharmacokinetics of Sirolimus in Stable Renal Transplant Patients after Multiple Oral Dose Administration
  The Journal of Clinical Pharmacology, 1997
• EFFECTS OF THE PHARMACOKINETIC INTERACTION BETWEEN ORALLY ADMINISTERED SIROLIMUS AND CYCLOSPORINE ON THE SYNERGISTIC PROLONGATION OF HEART ALLOGRAFT SURVIVAL IN RATS1
  Transplantation, 1996
• Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action
  Therapeutic Drug Monitoring, 1995
• SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO
  Transplantation, 1991
• Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
  The Journal of Antibiotics, 1975
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
  The Journal of Antibiotics, 1975